Alicia Bloomfield Selected Research

EC 0489

2/2011

Reducing undesirable hepatic clearance of a tumor-targeted vinca alkaloid via novel saccharopeptidic modifications.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alicia Bloomfield Research Topics

Disease

9	Neoplasms (Cancer) 01/2019 - 12/2008
1	Prostatic Neoplasms (Prostate Cancer) 01/2019
1	Weight Loss (Weight Reduction) 01/2019
1	Lung Neoplasms (Lung Cancer) 01/2016
1	Constipation 02/2011
1	Anaphylaxis (Anaphylactic Shock) 09/2009
1	Hypersensitivity (Allergy) 09/2009

Drug/Important Bio-Agent (IBA)

8	Folic Acid (Vitamin M)FDA LinkGeneric 12/2018 - 12/2008
6	Pharmaceutical PreparationsIBA 01/2019 - 12/2008
5	EC145IBA 12/2018 - 02/2011
4	AlkaloidsIBA 12/2018 - 02/2011
2	tubulysin BIBA 01/2019 - 06/2017
1	AntigensIBA 01/2019
1	Docetaxel (Taxotere)FDA Link 01/2019
1	Biological ProductsIBA 01/2019
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	Paclitaxel (Taxol)FDA LinkGeneric 12/2018
1	Cisplatin (Platino)FDA LinkGeneric 12/2018
1	EC0305IBA 06/2017
1	EC0531IBA 06/2017
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2016
1	HydrazinesIBA 01/2016
1	EC 0489IBA 02/2011
1	HaptensIBA 09/2009
1	Fluorescein (Funduscein)FDA LinkGeneric 09/2009
1	Fluorescein-5-isothiocyanate (FITC)IBA 09/2009

Therapy/Procedure

5	Therapeutics 01/2019 - 03/2014
1	Immunotherapy 09/2009